← Evidence map

ArticleMolecular therapy. Nucleic acids2025

CRISPR-directed exon skipping; friend or foe (opportunity or warning sign)?

Kelly H Banas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 40385634